1.Trimetazidine as adjunctive therapy for decreasing major adverse cardiac events in coronary artery disease patients undergoing reperfusion strategy: A meta-analysis of randomized controlled trials
Christdianzen Grace P. Saroca ; John David S. Tan ; Douglas P. Bailon ; Abigail Louise D. Te-Rosano ; Richard Henry P. Tiongco
Philippine Journal of Cardiology 2022;50(1):74-82
		                        		
		                        			
		                        			Trimetazidine as adjunctive therapy in cardioischemic patients has shown improvement in angina and left ventricular ejection fraction, but with conflicting evidence on hard clinical outcomes. This meta-analysis aims to compare the efficacy of trimetazidine versus placebo in reducing cardiac mortality and major adverse cardiac events (MACEs) in coronary artery disease patients after reperfusion strategies, whether percutaneous coronary intervention or thrombolysis. The primary outcomes examined were cardiac mortality and combined MACEs; secondary outcomes were repeat revascularization, heart failure after reperfusion, stent restenosis, recurrence of angina, and reinfarction. Trimetazidine in comparison to placebo was associated with lower cardiac mortality and combined MACEs, but results were not significant. Among secondary outcomes, only stent restenosis was significantly reduced (risk ratio, 0.53; 95% confidence interval, 0.34-0.83; P = 0.006). Further trials should be conducted with more standard dosing regimens, duration of therapy, and similar severities of ischemic disease.
		                        		
		                        		
		                        		
		                        	
2.Genetic polymorphisms in NAT1, NAT2, GSTM1, GSTP1 and GSTT1 and susceptibility to colorectal cancer among Filipinos
Eva Maria C. Cutiongco-de la Paz ; Corazon A. Ngelangel ; Virgilio P. Bañ ; ez ; Francisco T. Roxas ; Catherine Lynn T. Silao ; Jose B. Nevado Jr. ; Alberto B. Roxas ; Oliver G. , Florendo ; Ma. Cecilia M. Sison ; Orlino Bisquera, Jr ; Luminardo M. Ramos ; Elizabeth A. Nuqui ; Arnold Joseph M. Fernandez ; Maria Constancia O. Carrillo ; Beatriz J. Tiangco ; Aileen D. Wang ; Rosalyn H. Sebastian ; Richmond B. Ceniza ; Leander Linus Philip P. Simpao ; Lakan U. Beratio ; Eleanor A. Dominguez ; Albert B. Albay Jr. ; Alfredo Y. Pontejos Jr. ; Nathaniel W. Yang ; Arsenio A. Cabungcal ; Rey A. Desales ; Nelia S. Tan-Liu ; Sullian S. Naval ; Roberto M. Montevirge ; Catalina de Siena E. Gonda-Dimayacyac ; Pedrito Y. Tagayuna ; John A. Coloma ; Gil M. Vicente ; Higinio T. Mappala ; Alex C. Tapia ; Emmanuel F. Montana Jr. ; Jonathan M. Asprer ; Reynaldo O. Joson ; Sergio P. Paguio ; Tristan T. Chipongian ; Joselito F. David ; Florentino C. Doble ; Maria Noemi G. Pato ; Benito B. Bionat Jr ; Hans Francis D. Ferraris ; Adonis A. Guancia ; Eriberto R. Layda ; Andrew D. Dimacali ; Conrado C. Cajucom ; Richard C. Tia ; Mark U. Javelosa ; Regie Lyn P. Santos-Cortez ; Frances Maureen C. Rocamora ; Roemel Jeusep Bueno ; Carmencita D. Padilla
Acta Medica Philippina 2017;51(3):216-222
		                        		
		                        			
		                        			Objectives.  Polymorphisms  in  metabolic  genes  which  alter  rates  of    bioactivation    and    detoxification    have    been    shown    to    modulate  susceptibility  to  colorectal  cancer.  This  study  sought  to evaluate the colorectal cancer risk from environmental factors and  to  do  polymorphism  studies  on  genes  that  code  for  Phase  I  and  II  xenobiotic  metabolic  enzymes  among  Filipino  colorectal  cancer patients and matched controls. Methods. A total of 224 colorectal cancer cases and 276 controls from   the   Filipino   population   were   genotyped   for   selected   polymorphisms   in   GSTM1,   GSTP1,   GSTT1,   NAT1   and   NAT2.   Medical     and     diet     histories,     occupational     exposure     and     demographic     data     were     also     collected     for     all     subject     participants.Results.   Univariate   logistic   regression   of   non-genetic   factors   identified  exposure  to  UV  (sunlight)  (OR  1.99,  95%  CI:  1.16-3.39) and  wood  dust  (OR  2.66,  95%  CI:  1.21-5.83)  and  moldy  food  exposure  (OR  1.61,  95%  CI:1.11-2.35)  as  risk  factors;  while  the  NAT2*6B  allele  (recessive  model  OR  1.51,  95%  CI  :1.06-2.16; dominant  model  OR  1.87,  95%  CI:  1.05-3.33)  and  homozygous  genotype   (OR   2.19,   95%   CI:   1.19-4.03)   were   found   to   be   significant  among  the  genetic  factors.  After  multivariate  logistic  regression  of  both  environmental  and  genetic  factors,  only  UV  radiation  exposure  (OR  2.08, 95%  CI:  1.21-3.58)  and  wood  dust  exposure    (OR    2.08,    95%    CI:    0.95-5.30)    remained    to    be significantly  associated  with  increasing  colorectal  cancer  risk  in  the study population.Conclusion. This study demonstrated that UV sunlight and wood dust exposure play a greater role in influencing colorectal cancer susceptibility than genotype status from genetic polymorphisms of the GST and the NAT` genes.
		                        		
		                        		
		                        		
		                        			Colorectal Neoplasms
		                        			;
		                        		
		                        			 Polymorphism, Genetic
		                        			
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail